The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment ...
The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment ...
Connie Campbell was 11 years old when she discovered she had a type of brain tumor called medulloblastoma [a rare primary central nervous system tumor] just days after going on rollercoaster prompted ...
Tom Shaw is no longer able to walk and had to learn how to speak again after having a brain tumor removed. He’s sharing his story to encourage others to get checked early on and not to ignore symptoms ...
Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for patients with solid tumors. The Food and Drug Administration (FDA) approval of ...
The purpose of this study was to compare the efficacy and safety of subcutaneous, sublingual, oral specific immunotherapy in patients who suffer from allergic conditions to pollen from trees, grasses ...
Tecentriq Hybreza “can treat patients faster and in more accessible settings” and “offers patients with multiple cancer types and their physicians greater flexibility and choice of treatment ...
About six weeks after her symptoms began, she insisted on an ultrasound and was eventually diagnosed with Stage 3 borderline ovarian tumors, a type of pre-cancerous mass. “It’s ...